Rounding@IOWA episode 71: The 'Wild West' of biosimilars

Biologics are complex, high-cost treatments derived from living systems, used for immune-related disorders. Biosimilars are more affordable alternatives that are highly similar to biologics, with no significant clinical differences. The FDA supports biosimilar development to reduce costs, and various financial aids are available to help patients access these treatments. Join us as we discuss these important topics. CME credit available for listening.